BETHLEHEM, PA — B. Braun Medical Inc. has expanded its DUPLEX® Container portfolio with the launch of Cefazolin 3 g, offering a new dosage option designed for surgical infection prevention in patients weighing 120 kg or more. This addition aims to provide a ready-to-use, accurate dosing solution that simplifies treatment for healthcare professionals.
Cefazolin, a commonly prescribed antibiotic to prevent infections before, during, or after surgery, is now available in 1 g, 2 g, and the newly introduced 3 g strength under the DUPLEX Container system. Engineered for efficiency, these containers streamline medication administration by separating the premeasured medication and diluent until the moment of use, ensuring consistency and convenience.
The DUPLEX Container is user-friendly and helps reduce workload and errors for healthcare teams. Activation requires only folding, squeezing, and shaking, eliminating the need for complex reconstitution processes. With a minimum shelf life of 18 months and compatibility with automated medication dispensing systems, this ready-to-activate, flexible IV system is designed for effective integration in hospitals.
For healthcare providers, the container’s advanced features also include a barcode system that references the admixture, lot number, and expiration date. This innovation enhances patient safety, assists in inventory tracking, automates patient charting, and supports reimbursement procedures.
The addition of Cefazolin 3 g enables B. Braun to address an important need for patients requiring higher antibiotic dosages while supporting practitioners with a simplified, reliable solution to deliver care effectively. The DUPLEX Container portfolio continues to reflect B. Braun’s commitment to leveraging technology to improve healthcare delivery.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.